495 related articles for article (PubMed ID: 17225721)
1. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Malde B; Regalado J; Greenberger PA
Ann Allergy Asthma Immunol; 2007 Jan; 98(1):57-63. PubMed ID: 17225721
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitor (ACE-I)- and angiotensin receptor blocker (ARB)-related angioedema: a neglected issue in daily practice in Greece.
Symvoulakis EK; Kyrmizakis DE; Drivas EI; Bizakis J; Velegrakis GA; Lionis C
Eur J Gen Pract; 2007; 13(4):239-41. PubMed ID: 18324507
[TBL] [Abstract][Full Text] [Related]
3. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment.
Cicardi M; Zingale LC; Bergamaschini L; Agostoni A
Arch Intern Med; 2004 Apr; 164(8):910-3. PubMed ID: 15111379
[TBL] [Abstract][Full Text] [Related]
4. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
[TBL] [Abstract][Full Text] [Related]
5. Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology.
Chiu AG; Krowiak EJ; Deeb ZE
Laryngoscope; 2001 Oct; 111(10):1729-31. PubMed ID: 11801934
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
[TBL] [Abstract][Full Text] [Related]
7. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
[TBL] [Abstract][Full Text] [Related]
8. Analysis of recurrent angiotensin converting enzyme inhibitor-induced angioedema.
Roberts DS; Mahoney EJ; Hutchinson CT; Aliphas A; Grundfast KM
Laryngoscope; 2008 Dec; 118(12):2115-20. PubMed ID: 19029862
[TBL] [Abstract][Full Text] [Related]
9. [Iatrogenic angioedema: the role of angiotensin converting enzyme inhibitor and angiotensin II receptor blockers].
Roskiewicz F; Andriamanana I; Gras-Champel V; Andrejak M; Massy ZA
Nephrol Ther; 2007 Jun; 3(3):89-95. PubMed ID: 17540310
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
11. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
12. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.
Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK
J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317
[TBL] [Abstract][Full Text] [Related]
13. Hereditary angioedema presenting in late middle age after angiotensin-converting enzyme inhibitor treatment.
Ricketti AJ; Cleri DJ; Ramos-Bonner LS; Vernaleo JR
Ann Allergy Asthma Immunol; 2007 Apr; 98(4):397-401. PubMed ID: 17458439
[TBL] [Abstract][Full Text] [Related]
14. Reduction of amiodarone pulmonary toxicity in patients treated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kosseifi SG; Halawa A; Bailey B; Micklewright M; Roy TM; Byrd RP
Ther Adv Respir Dis; 2009 Dec; 3(6):289-94. PubMed ID: 19850648
[TBL] [Abstract][Full Text] [Related]
15. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists.
Kyrmizakis DE; Papadakis CE; Liolios AD; Karatzanis AD; Malandrakis S; Skoulakis CE; Bizakis JG; Velegrakis GA
Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1416-9. PubMed ID: 15611402
[TBL] [Abstract][Full Text] [Related]
17. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
Fang W; Oreopoulos DG; Bargman JM
Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
[TBL] [Abstract][Full Text] [Related]
18. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation.
Jennings DL; Taber DJ
Ann Pharmacother; 2008 Jan; 42(1):116-20. PubMed ID: 18094340
[TBL] [Abstract][Full Text] [Related]
19. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
Han SW; Won YW; Yi JH; Kim HJ
Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis.
McCall KL; Craddock D; Edwards K
Pharmacotherapy; 2006 Sep; 26(9):1297-306. PubMed ID: 16945052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]